Haiwang Biology: The stock has deviated from the value for two consecutive days, with a total increase exceeding 20%, indicating potential risks.

Ocean King Bios announcement said that the company's stock price had deviated by more than 20% for two consecutive trading days from January 13 to 14, 2026, which was considered abnormal volatility. After verification, there were no corrections or supplements to the company's previous disclosure information; no undisclosed significant information affecting stock prices found in media reports; production and operation were normal with no significant changes in internal and external environments; the company, controlling shareholders, and ultimate controller had no undisclosed significant matters to disclose; during the abnormal volatility period, the controlling shareholders, ultimate controller, and their concerted parties did not buy or sell the company's stock; there was no violation of fair disclosure regulations. The company reminded investors to invest rationally and be aware of risks.